Financials
- Market Capitalization 24.15 M
- Employee 83
- Founded 2002
- CEO N/A
- Website www.aytubio.com
- Headquarter Delaware, United States
- FIGI BBG000VC2PT9
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4424 | RMTI Rockwell Medical, Inc. - Common Stock | 8.17 USD | +5.42% | +2.77% | +17.39% | +327.75% | 32.93 M USD | ||
| 4492 | TXMD TherapeuticsMD, Inc. - Common Stock | 2.22 USD | 0.00% | +7.77% | +9.36% | +111.43% | 25.70 M USD | ||
| 4520 | BFRI Biofrontera Inc. - Common Stock | 1.59 USD | +6.71% | +7.43% | +34.75% | +84.88% | 23.62 M USD | ||
| 4831 | AKAN Akanda Corp. - Common Shares | 3.89 USD | -8.04% | 0.00% | -39.78% | +4.85% | 7.72 M USD |
Frequently asked questions about AYTU BioPharma, Inc. Common Stock
What is the AYTU BioPharma, Inc. Common Stock stock price today?
The current price of AYTU BioPharma, Inc. Common Stock (AYTU) is 2.25. Over the past 24 hours, the stock has changed by +0.45%. Follow the AYTU chart for real-time price dynamics.
What is the stock ticker of AYTU BioPharma, Inc. Common Stock?
AYTU BioPharma, Inc. Common Stock trades under the ticker AYTU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AYTU BioPharma, Inc. Common Stock stock going up?
AYTU has changed by -4.26% over the last week, +4.17% over the last month, and -4.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of AYTU BioPharma, Inc. Common Stock?
AYTU BioPharma, Inc. Common Stock currently has a market capitalization of 24.15 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were AYTU BioPharma, Inc. Common Stock earnings last quarter?
Last quarter, AYTU BioPharma, Inc. Common Stock reported earnings of -0.53 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was AYTU BioPharma, Inc. Common Stock revenue for the last quarter?
AYTU BioPharma, Inc. Common Stock reported quarterly revenue of 12.41 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was AYTU BioPharma, Inc. Common Stock net income for the last quarter?
AYTU BioPharma, Inc. Common Stock reported net income of -5.62 M for the last quarter. The previous quarter showed -10.58 M, which means net income changed by +46.92%.
How many employees does AYTU BioPharma, Inc. Common Stock have?
As of the latest available data, AYTU BioPharma, Inc. Common Stock has 83 employees. Workforce size can provide additional context about the company's scale and operations.
What is AYTU BioPharma, Inc. Common Stock EBITDA?
AYTU BioPharma, Inc. Common Stock EBITDA is -2.85 M, and its EBITDA margin is -22.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AYTU BioPharma, Inc. Common Stock stock?
You can buy AYTU BioPharma, Inc. Common Stock (AYTU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AYTU BioPharma, Inc. Common Stock stock?
Investing in AYTU BioPharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AYTU chart and related analysis on metatrader.com as part of your research.